mFolfirinox-Bevacizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A modified, dose-adjusted regimen consisting of fluorouracil, leucovorin, oxaliplatin and irinotecan (mFOLFIRINOX), and bevacizumab that may be used for the treatment of appendiceal adenocarcinoma, colorectal cancer, and small bowel adenocarcinoma.

**Synonyms:** - Bevacizumab Plus mFolfirinox - Bevacizumab-mFolfirinox - Modified Folfirinox-Bevacizumab - mFolfirinox Plus Bevacizumab - mFolfirinox-Avastin - mFolfirinox-Bevacizumab - mFolfirinox/Bevacizumab